BAKER BROS ADVISORS LLC Insider Trading for April 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of BAKER BROS ADVISORS LLC for April 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 7.26 | 20,000 | 145,200 | 0 | |
| Apr 28 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 7.26 | 20,000 | 145,200 | 0 | |
| Apr 28 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 7.26 | 20,000 | 145,200 | 0 | |
| Apr 28 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | M | 7.26 | 20,000 | 145,200 | 787,237 | 767.2 K to 787.2 K (+2.61 %) |
| Apr 28 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | M | 7.26 | 20,000 | 145,200 | 29,161,795 | 29.1 M to 29.2 M (+0.07 %) |
| Apr 28 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | M | 7.26 | 20,000 | 145,200 | 4,374,099 | 4.4 M to 4.4 M (+0.46 %) |
| Apr 21 2017 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 2.84 | 399,984 | 1,135,955 | 399,984 | |
| Apr 05 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.43 | 8,487 | 20,623 | 133,666 | 125.2 K to 133.7 K (+6.78 %) |
| Apr 05 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.43 | 8,487 | 20,623 | 9,331,989 | 9.3 M to 9.3 M (+0.09 %) |
| Apr 05 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.43 | 8,487 | 20,623 | 1,026,437 | 1 M to 1 M (+0.83 %) |
| Apr 04 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 133.67 | 142 | 18,981 | 767,237 | 767.1 K to 767.2 K (+0.02 %) |
| Apr 04 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 133.67 | 142 | 18,981 | 29,141,795 | 29.1 M to 29.1 M (0.00 %) |
| Apr 04 2017 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 133.67 | 142 | 18,981 | 4,354,099 | 4.4 M to 4.4 M (0.00 %) |
| Apr 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 31.49 | 634 | 19,965 | 320,627 | 320 K to 320.6 K (+0.20 %) |
| Apr 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 31.49 | 634 | 19,965 | 11,350,962 | 11.4 M to 11.4 M (+0.01 %) |
| Apr 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 31.49 | 634 | 19,965 | 1,760,293 | 1.8 M to 1.8 M (+0.04 %) |
| Apr 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 31.49 | 634 | 19,965 | 34,019 | 33.4 K to 34 K (+1.90 %) |
| Apr 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 31.49 | 634 | 19,965 | 194,678 | 194 K to 194.7 K (+0.33 %) |
| Apr 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 31.49 | 634 | 19,965 | 214,942 | 214.3 K to 214.9 K (+0.30 %) |